Leucine, a B2B SaaS startup, has raised $7 million to develop its AI capabilities and widen its outreach to additional facilities and customers. Leucine claims its platform can be implemented in just eight weeks.
Through its Compliance Cloud platform, Leucine offers real-time performance monitoring, compliance management, and actionable insights, utilising AI to digitise workflows and offer proactive compliance insights.
“This latest funding round will enable Leucine to bring the power of LLMs (large language models) and associated technologies to make significant advances in pharma manufacturing,” said Rohit Jain, Co-founder and Partner at Pravega Ventures.